Total Payments
$132,144
2024 Payments
$12,670
Companies
80
Transactions
1,164
Medicare Patients
23,780
Medicare Billing
$5.5M
Payment Breakdown by Category
Other$68,752 (52.0%)
Food & Beverage$28,898 (21.9%)
Consulting$25,244 (19.1%)
Travel$8,877 (6.7%)
Education$372.61 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $33,968 | 15 | 25.7% |
| Food and Beverage | $28,898 | 1,082 | 21.9% |
| Consulting Fee | $25,244 | 11 | 19.1% |
| Honoraria | $11,800 | 5 | 8.9% |
| Long term medical supply or device loan | $11,458 | 2 | 8.7% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $11,425 | 5 | 8.6% |
| Travel and Lodging | $8,877 | 27 | 6.7% |
| Education | $372.61 | 10 | 0.3% |
| Entertainment | $57.54 | 3 | 0.0% |
| Grant | $43.02 | 3 | 0.0% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
General
$132,144
1,163 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PORTOLA PHARMACEUTICALS, INC. | $20,720 | 26 | $0 (2018) |
| Cardiovascular Systems Inc. | $13,339 | 42 | $0 (2023) |
| ABIOMED | $12,864 | 15 | $0 (2024) |
| AngioDynamics, Inc. | $12,042 | 12 | $0 (2024) |
| PFIZER INC. | $11,751 | 55 | $0 (2024) |
| EKOS Corporation | $9,945 | 19 | $0 (2019) |
| Medicure Pharma Inc. | $8,207 | 5 | $0 (2018) |
| Relypsa, Inc. | $6,701 | 13 | $0 (2019) |
| Cardinal Health 200 LLC | $5,878 | 60 | $0 (2021) |
| Boston Scientific Corporation | $3,163 | 59 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,670 | 167 | AngioDynamics, Inc. ($7,550) |
| 2023 | $11,426 | 171 | AngioDynamics, Inc. ($4,060) |
| 2022 | $4,178 | 133 | Siemens Medical Solutions USA, Inc. ($1,000) |
| 2021 | $5,745 | 187 | BOSTON SCIENTIFIC CORPORATION ($1,825) |
| 2020 | $14,152 | 106 | PFIZER INC. ($11,199) |
| 2019 | $5,558 | 138 | Cardiovascular Systems Inc. ($3,228) |
| 2018 | $58,748 | 143 | PORTOLA PHARMACEUTICALS, INC. ($20,720) |
| 2017 | $19,667 | 119 | Cardiovascular Systems Inc. ($6,738) |
All Payment Transactions
1,164 individual payment records from CMS Open Payments — Page 1 of 47
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | AngioDynamics, Inc. | Auryon Laser System 100-120 Vac (Device) | Long term medical supply or device loan | In-kind items and services | $7,500.00 | General |
| Category: ET | ||||||
| 12/30/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 12/24/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $12.25 | General |
| Category: Cardiology | ||||||
| 12/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Obesity | ||||||
| 12/17/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 12/17/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 12/12/2024 | Abbott Laboratories | OPTIS (Device) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Vascular | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.91 | General |
| Category: Cardiovascular | ||||||
| 12/12/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $10.60 | General |
| Category: Cardiology | ||||||
| 12/11/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $102.46 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/11/2024 | Imperative Care, Inc | PRODIGY CATHETER (Device) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: VASCULAR | ||||||
| 12/11/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/10/2024 | Endologix LLC | — | Food and Beverage | In-kind items and services | $33.47 | General |
| 12/10/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: EndoVenous Therapies | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.14 | General |
| Category: Cardiovascular | ||||||
| 12/02/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $7.73 | General |
| Category: Cardiovascular | ||||||
| 11/27/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $95.76 | General |
| Category: Cardiology | ||||||
| 11/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Obesity | ||||||
| 11/20/2024 | Endologix LLC | Alto Abdominal Stent Graft System (Device) | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/18/2024 | Abbott Laboratories | ENSITE PRECISION (Device) | Food and Beverage | In-kind items and services | $171.91 | General |
| Category: Electrophysiology | ||||||
| 11/18/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $10.79 | General |
| Category: Cardiology | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/13/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 52 | 6,636 | 19,929 | $5.6M | $1.5M |
| 2022 | 55 | 5,609 | 14,872 | $3.9M | $1.1M |
| 2021 | 54 | 5,898 | 16,992 | $5.2M | $1.4M |
| 2020 | 56 | 5,637 | 17,953 | $5.7M | $1.5M |
Total Patients
23,780
Total Services
69,746
Medicare Billing
$5.5M
Procedure Codes
220
All Medicare Procedures & Services
220 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 37225 | Removal of plaque in arteries of leg | Office | 2023 | 42 | 63 | $1.7M | $377,728 | 22.1% |
| 37229 | Removal of plaque in artery of leg, initial vessel | Office | 2023 | 16 | 24 | $658,596 | $170,996 | 26.0% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 159 | 163 | $344,419 | $107,621 | 31.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 280 | 282 | $309,169 | $94,784 | 30.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 487 | 618 | $305,751 | $86,069 | 28.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 374 | 1,380 | $220,800 | $69,199 | 31.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 298 | 461 | $210,860 | $64,722 | 30.7% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 282 | 568 | $113,600 | $59,634 | 52.5% |
| 37252 | Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | Office | 2023 | 54 | 78 | $229,853 | $59,583 | 25.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 252 | 1,009 | $251,500 | $43,618 | 17.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 394 | 598 | $135,148 | $38,693 | 28.6% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 277 | 994 | $123,255 | $38,487 | 31.2% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 149 | 153 | $91,188 | $27,547 | 30.2% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 187 | 795 | $80,293 | $24,990 | 31.1% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 353 | 636 | $78,853 | $23,959 | 30.4% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 222 | 270 | $87,720 | $22,702 | 25.9% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 136 | 142 | $67,786 | $19,180 | 28.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 183 | 467 | $58,375 | $18,267 | 31.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 124 | 126 | $60,102 | $16,804 | 28.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 112 | 139 | $44,480 | $13,957 | 31.4% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 80 | 84 | $37,968 | $10,851 | 28.6% |
| 37253 | Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | Office | 2023 | 50 | 76 | $40,720 | $10,634 | 26.1% |
| 93975 | Complete ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2023 | 47 | 47 | $31,689 | $9,274 | 29.3% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 44 | 174 | $27,318 | $8,591 | 31.4% |
| 99091 | Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days | Office | 2023 | 105 | 190 | $26,596 | $8,321 | 31.3% |
About Dr. Mahir Elder, MD
Dr. Mahir Elder, MD is a Cardiovascular Disease healthcare provider based in Detroit, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962427260.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mahir Elder, MD has received a total of $132,144 in payments from pharmaceutical and medical device companies, with $12,670 received in 2024. These payments were reported across 1,164 transactions from 80 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($33,968).
As a Medicare-enrolled provider, Elder has provided services to 23,780 Medicare beneficiaries, totaling 69,746 services with total Medicare billing of $5.5M. Data is available for 4 years (2020–2023), covering 220 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Detroit, MI
- Active Since 07/13/2006
- Last Updated 03/07/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1962427260
Products in Payments
- BEVYXXA (Drug) $20,720
- Impella (Device) $12,864
- Auryon Laser System 100-120 Vac (Device) $11,458
- EKOSONIC (Device) $9,945
- Aggrastat (tirofiban HCl) (Drug) $8,207
- VYNDAQEL (Drug) $7,792
- Peripheral Orbital Atherectomy System (Device) $7,358
- Veltassa (Drug) $6,701
- Coronary Orbital Atherectomy System (Device) $5,500
- Kerendia (Drug) $2,993
- TRELEGY ELLIPTA (Drug) $1,494
- ELIQUIS (Drug) $1,211
- LifeVest (Device) $1,144
- Assure WCD (Device) $1,041
- XARELTO (Drug) $1,034
- Indigo (Device) $911.84
- GENERAL VASCULAR INTERVENTION (Device) $900.00
- General - Vascular Intervention (Device) $675.00
- Penumbra System (Device) $561.53
- Repatha (Biological) $553.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Detroit
Dr. Tamam Mohamad
Cardiovascular Disease — Payments: $1.4M
Cardiovascular Disease $1.4M
Wayne Douglas Weaver, M.d, M.D
Cardiovascular Disease — Payments: $360,582
Cardiovascular Disease $360,582
Dr. Brian O'neill, M.d, M.D
Cardiovascular Disease — Payments: $182,193
Cardiovascular Disease $182,193
Dr. Brian Ference, Md, MD
Cardiovascular Disease — Payments: $160,503
Cardiovascular Disease $160,503
David Lanfear, M.d, M.D
Cardiovascular Disease — Payments: $160,449
Cardiovascular Disease $160,449
Dr. Zaher Hakim, M.d, M.D
Cardiovascular Disease — Payments: $93,632
Cardiovascular Disease $93,632